These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma. Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194 [TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders. Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691 [TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743 [TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis. Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744 [TBL] [Abstract][Full Text] [Related]
7. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
8. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer. Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research. Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504 [TBL] [Abstract][Full Text] [Related]
10. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA. Junqueira-Neto S; Batista IA; Costa JL; Melo SA Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027 [TBL] [Abstract][Full Text] [Related]
11. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Shetti D; Mallela VR; Ye W; Sharif M; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K Crit Rev Oncol Hematol; 2024 Aug; 200():104391. PubMed ID: 38795877 [TBL] [Abstract][Full Text] [Related]
12. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust! Fontanilles M; Duran-Peña A; Idbaih A Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561 [TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine. Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643 [TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review). Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333 [TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy: From Basic Research to Clinical Practice. Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904 [TBL] [Abstract][Full Text] [Related]
16. Serum liquid biopsy for brain tumours: a scoping analysis of practicable approaches in low- and middle-income countries. Bajwa MH; Khan MA; Urooj F; Khalid MU; Enam SA; Aziz HF; Siddiqui K; Bari ME; Mughal N J Pak Med Assoc; 2024 Mar; 74(3 (Supple-3)):S30-S51. PubMed ID: 39262064 [TBL] [Abstract][Full Text] [Related]
17. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application. Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662 [TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy: Current Status and Future Perspectives. Mader S; Pantel K Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023 [TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma. Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]